About: Management of West syndrome during COVID-19 pandemic: A viewpoint from South Asian West Syndrome Research Group

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Management of West syndrome during COVID-19 pandemic: A viewpoint from South Asian West Syndrome Research Group Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Management of West syndrome during COVID-19 pandemic: A viewpoint from South Asian West Syndrome Research Group
Creator	Kumar, Amit Madaan, Priyanka Chand, Prem Linn, Kyaw Mynak, Mimi Poude, Prakash Sahu, Jitendra Wanigasinghe, Jithangi
Source	PMC
abstract	In the wake of the pandemic COVID-19 and nationwide lockdowns gripping many countries globally, the national healthcare systems are either overwhelmed or preparing to combat this pandemic. Despite all the containment measures in place, experts opine that this novel coronavirus is here to stay as a pandemic or an endemic. Hence, it is apt to be prepared for the confrontation and its aftermath. From protecting the vulnerable individuals to providing quality care for all health conditions and maintaining essential drug supplies, it is going to be a grueling voyage. Preparedness to sustain optimal care for each health condition is a must. With a higher risk for severe COVID-19 disease in infants, need of high-dose hormonal therapy with a concern of consequent severe disease, presence of comorbidities, and a need for frequent investigations and follow-up; children with West syndrome constitute a distinctive group with special concerns. In this viewpoint, we discuss the important issues and concerns related to the management of West syndrome during COVID-19 pandemic in the South Asian context and provide potential solutions to these concerns based on the current evidence, adeptness, and consensus. Some plausible solutions include the continuation of containment and mitigation measures for COVID-19, therapeutic decision- making for West syndrome based on risk stratification, and tele-epileptology.
has issue date	2020-08-31(xsd:dateTime)
bibo:doi	10.1016/j.eplepsyres.2020.106453
has license	no-cc
schema:url	https://doi.org/10.1016/j.eplepsyres.2020.106453
resource representing a document's title	Management of West syndrome during COVID-19 pandemic: A viewpoint from South Asian West Syndrome Research Group
has PubMed Central identifier	PMC7456842
schema:publication	Epilepsy Res
resource representing a document's body	covid:PMC7456842#body_text
is schema:about of	named entity 'COVID-19' named entity 'viewpoint' named entity 'West syndrome' named entity 'COVID-19 pandemic' named entity 'infection' named entity 'Valproate' named entity 'pharmaceutical companies' named entity 'infection' named entity 'systematic review' named entity 'hormonal therapy' named entity 'COVID' named entity 'COVID-19 pandemic' named entity 'vigabatrin' named entity 'West syndrome' named entity 'challenging times' named entity 'SARS-CoV-2' named entity 'Antiepileptic' named entity 'epileptic spasms' named entity 'high-dose' named entity 'end-to-end encryption' named entity 'COVID' named entity 'hormonal therapy' named entity 'mobile apps' named entity 'Practice Guidelines' named entity 'hormonal therapy' named entity 'smartphone' named entity 'South Asia' named entity 'steroids' named entity 'high-dose' named entity 'Harini' named entity 'PubMed' named entity 'antiseizure medications' named entity 'ACTH' named entity 'United States' named entity 'prednisolone' named entity 'infection' named entity 'comorbidity' named entity 'EEG' named entity 'Epilepsy' named entity 'zonisamide' named entity 'epilepsy' named entity 'COVID' named entity 'infantile spasms' named entity 'febrile' named entity 'contraindicated' named entity 'community transmission' named entity 'first-line treatment' named entity 'COVID-19' named entity 'tuberous sclerosis complex' named entity 'COVID' named entity 'hypsarrhythmia' named entity 'vigabatrin' named entity 'EEG' named entity 'SARS-CoV-2' named entity 'steroids' named entity 'COVID' named entity 'seizures' named entity 'etiology' named entity 'hormonal therapy' named entity 'corticosteroid' named entity 'medical conditions' named entity 'semiology' named entity 'spasticity' named entity 'fever' named entity 'community transmission' named entity 'COVID-19 disease' named entity 'Amit Kumar' named entity 'comorbidities' named entity 'vigabatrin' named entity 'COVID' named entity 'telehealth' named entity 'EEG' named entity 'supply chain' named entity 'hypsarrhythmia' named entity 'prognostic' named entity 'Internet' named entity 'viral replication'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software